NAN 2 Infant Formula 6-12 months
Therapeutic agent (verify pharmacological class)
What it is used for
For follow-up milk feeding from 6 months onwards [when breast milk is not available or has to be supple-mented], as a complement to weaning foods, use NAN 2 as a follow up to NAN 1 or LACTOGEN 1. Clinical selection for NAN 2 Infant Formula 6-12 months should follow culture results where relevant, Kenya STG/EML recommendations, and the current product SmPC. Class context: Therapeutic agent (verify pharmacological class). Confirm site-specific dose, duration and monitoring before prescribing.
Warnings
Obtain allergy and medication history. Adjust for renal/hepatic impairment, pregnancy, lactation, extremes of age and interacting drugs. Use the lowest effective dose for the shortest appropriate duration. Monitor for expected class adverse effects.
Possible side effects
Adverse reactions vary by agent. Counsel on common predictable effects and serious warning symptoms (allergy, severe rash, jaundice, unusual bleeding, severe GI symptoms, neurological changes). Report suspected ADRs via national pharmacovigilance channels.
Storage
Store as labelled. Keep out of reach of children.
No reviewed patient-education article is available. The fields shown are from the currently verified medicine record and unavailable fields are not inferred.